IMAGINE: Pilot Trial of a Digital Group Intervention to Prevent Perinatal Depression
Launched by UNIVERSITY OF WASHINGTON · Dec 19, 2024
Trial Information
Current as of July 05, 2025
Recruiting
Keywords
ClinConnect Summary
The IMAGINE trial is a research study looking at a digital group program designed to help prevent depression during pregnancy and after childbirth. This program uses techniques from cognitive behavioral therapy, which helps people change negative thoughts and behaviors. The main goal of the trial is to see if participating in this program can lower depression scores in women who are at risk for perinatal depression and to determine if the program is easy to use and acceptable to participants.
To be eligible for the study, you must be a woman aged 16 or older who is either pregnant or has given birth within the last six months. You should also be at higher risk for depression but not currently experiencing major depression. If you qualify, you'll be randomly assigned to either take part in the IMAGINE program for 12 weeks or receive standard care. Throughout the study, you'll fill out questionnaires to help researchers track your mood and overall experience. This trial is currently recruiting, and participants will need access to a smartphone and a stable mental health treatment plan if they are receiving other mental health services.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Pregnant or up to 6 months postpartum
- • Age 16 or over
- • At elevated risk of perinatal depression (per USPSTF)
- • Speaks English or Spanish
- • PHQ9\<15 and no current major depression
- • Access to a smartphone with cellular data at least 3 days per week
- • If receiving other mental healthcare services, has been established in care at least 6 months and on stable treatment regimen
- • Exclusion Criteria: none
About University Of Washington
The University of Washington (UW) is a leading academic institution renowned for its commitment to advancing healthcare through innovative research and clinical trials. With a robust network of interdisciplinary teams, UW fosters collaboration among top-tier researchers, clinicians, and healthcare professionals, aiming to translate scientific discoveries into impactful treatments and interventions. The university is dedicated to ethical research practices and participant safety, ensuring rigorous adherence to regulatory standards in all clinical trials. Through its state-of-the-art facilities and extensive expertise, UW strives to address pressing health challenges and improve patient outcomes on a local and global scale.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Seattle, Washington, United States
Patients applied
Trial Officials
Keshet Ronen, PhD, MPH
Principal Investigator
University of Washington
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported